Covid-19 roundup: EU opts in­to 80M more Mod­er­na vac­cine dos­es; Boehringer In­gel­heim takes its an­ti­bod­ies in­to the clin­ic

On the heels of its unan­i­mous 20-0 ad­comm vote in the US, Mod­er­na has an­nounced a new deal for its Covid-19 vac­cine in Eu­rope.

The Eu­ro­pean Com­mis­sion has ex­er­cised an op­tion to pur­chase an ad­di­tion­al 80 mil­lion dos­es of the shot, Mod­er­na said Fri­day morn­ing, bring­ing its com­mit­ment to 160 mil­lion dos­es for the con­ti­nent. De­liv­er­ies are ex­pect­ed to be­gin quick­ly should the EMA is­sue an au­tho­riza­tion af­ter CHMP meets to dis­cuss its mer­its on Jan. 6.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER